NRC NRC Health
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.…
Industry Peers
Health Information ServicesKey Statistics
About NRC Health (NASDAQ: NRC)
›
NRC Health (NASDAQ: NRC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 357 employees.
The shares were at 24.99 USD on 19 November 2026, up 80.8% over 52 weeks. Its 52-week range is 11.73 USD to 27.60 USD: the price is 9.5% below the high and 113.0% above the low.
At a market capitalisation of 530.33M USD, it trades at 92.6 times trailing earnings and 23.6 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a premium of 120% for NRC. It pays a dividend yielding 2.45% (it pays out 237% of its earnings).
NRC Health reports return on equity of 82.9%, an operating margin of 13.4% and revenue up 11.0% year over year.
Its debt exceeds its cash by 99.61M USD, a debt-to-equity ratio of 5.65. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 27.00 USD is 8.0% above the current price. The next earnings report is expected on 2 February 2027.